<DOC>
	<DOCNO>NCT01903278</DOCNO>
	<brief_summary>This study confirm potential effect assess safety new bio-product Pegylated Recombinant Consensus Interferon Variant Solution Injection ( PEG-IFN-SA ) Ribavirin（RBV） treatment Chronic hepatitis C previously treat Interferon .</brief_summary>
	<brief_title>Efficacy Safety Study PEG-IFN-SA Ribavirin Treat Chronic Hepatitis C</brief_title>
	<detailed_description>Total 720 subject divide two group treat separately accord HCV genotype（genotype 2,3 non-genotype 2,3 ) . With 2:1 ratio experimental group positive-control group ( Peginterferon alfa-2a ( Pegasys ) plus RBV ) , 216 subject genotype 2,3 504 subject non-genotype2,3 enrol . Accordingly , PEG-IFN-SA weekly RBV twice day ( bid ) give 24 week 48 week respectively HCV genotype 2,3 HCV non-genotype 2,3 .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Age 18 65 year Body Mass Index ( BMI ) 1830 Chronic hepatitis C , diagnose accord Chinese guideline Hepatitis C ( year 2004 ) Detectable serum HCVRNA quantitative polymerase chain reaction assay positive antiHCV antibody Female subject childbearing age history menopause negative pregnancy test , female male ( include partner ) subject require conduct adequate contraception since screen 6 month treatment Volunteered participate study , understood sign informed consent Previous IFN treat patient Hepatotoxic drug systematically use two week within past 6 month Systemic therapy potent immunomodulatory agent adrenocorticotropic hormone , thymosin α1 , etc two week within past 6 month , include corticosteroid nasal spray , inhaled steroid / topical steroid Coinfection HAV , HBV , HEV , EBV , CMV HIV Evidences hepatic decompensation , include limited serum total bilirubin &gt; 2 time upper limit normal ( ULN ) ; serum albumin &lt; 35g/L ; prothrombin activity ( PTA ) &lt; 60 % ; ascites , upper gastrointestinal bleeding hepatic encephalopathy ; ChildPugh score B/C grade Diagnosed primary hepatocellular carcinoma support evidence include limited AFP &gt; l00ng/ml , suspicious liver nodule image examination Liver diseases cause HCV infection , include alcoholic liver disease , nonalcoholic steatohepatitis , druginduced hepatitis , autoimmune hepatitis ( antinuclear antibody titer high 1:100 ) , hepatolenticular degeneration ( Wilson 's disease ) hemochromatosis , etc . White blood cell count &lt; 3×109/L ; Neutrophil count &lt; 1.5×109/L ; platelet count &lt; 90×109/L ; hemoglobin low limit normal Serum creatinine ULN Serum creatine kinase &gt; 3 ULN Diabetes mellitus Poorly control Thyroid Diseases Poorly control hypertension ( systolic blood pressure &gt; 140mmHg , diastolic blood pressure &gt; 90 mmHg ) hypertension relate retinal lesion Immunodeficiency autoimmune disease include limited inflammatory bowel disease , systemic lupus erythematosus , rheumatoid arthritis , multiple sclerosis , scleroderma , Sjogren 's syndrome , autoimmune thrombocytopenia , etc . Psychiatric nervous system disorder , include history Psychiatric illness family history ( especially depression , depressive tendency , epilepsy hysteria , etc . ) Severe cardiovascular disease ( New York Heart Association functional class ( NYHA ) Ⅲ level , myocardial infarction occur within past 6 month PTCA perform within past 6 month , unstable angina , uncontrolled arrhythmia ) Serious blood disorder ( kind anemia , hemophilia , etc . ) Severe kidney disease ( chronic kidney disease , renal insufficiency , etc . ) Serious digestive disease ( gastrointestinal ulcer , colitis , etc . ) Severe respiratory disease ( pneumonia , chronic obstructive pulmonary disease , interstitial lung disease , etc . ) Retinal disease ( retinal exfoliation , macular hole , retinal tumor , etc . ) Malignancies Function organ transplant Allergies severe allergy , especially allergic study drug ingredient study drug Evidence alcohol drug abuse ( average alcohol consumption male &gt; 40g / day , female &gt; 20g / day ) Pregnant lactate woman Usage prohibition drug study Participated clinical trial 3 month prior screen Unwilling sign inform consent adhere treatment requirement Other condition suitable study judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>interferon</keyword>
	<keyword>ribavirin</keyword>
	<keyword>sustained virological response</keyword>
</DOC>